SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-056460
Filing Date
2006-03-16
Accepted
2006-03-16 14:28:36
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1713382
2 NEKTAR THERAPEUTICS' RESTRICTED STOCK UNIT NOTICES AND AGREEMENT dex1019.htm EX-10.19 37350
3 NEKTAR THERAPEUTICS 2000 NON-OFFICER EQUITY INCENTIVE PLAN dex1028.htm EX-10.28 40367
4 NEKTAR THERAPEUTICS' SEVERANCE BENEFIT PLAN, AS AMENDED dex1046.htm EX-10.46 39319
5 SUMMARY OF VARIABLE COMPENSATION PLAN dex1047.htm EX-10.47 3925
6 SUBSIDIARIES OF NEKTAR THERAPEUTICS dex211.htm EX-21.1 1830
7 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2632
8 CERTIFICATION OF PEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7382
9 CERTIFICATION OF PFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 7511
10 SECTION 1350 CERTIFICATIONS dex321.htm EX-32.1 4612
  Complete submission text file 0001193125-06-056460.txt   1859901
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 06691294
SIC: 2834 Pharmaceutical Preparations